US · Healthcare · Medical Devices
EPS came in at 1.60 against a street estimate of 1.38 — a beat of 15.9%.
Analysts rate Integer Holdings Corp a strong buy (9 buy, 1 hold, 0 sell out of 10) with an average price target of $121.80.
| Fund | Stake |
|---|---|
| BlackRock Inc | 15.61% |
| Vanguard Portfolio Management, LLC | 6.02% |
| Amvescap Plc. | 5.79% |
| Dimensional Fund Advisors, Inc. | 4.79% |
| Nomura Holdings Inc | 4.57% |
| Morgan Stanley - Brokerage Accounts | 4.53% |
| Vanguard Capital Management, LLC | 4.52% |
| State Street Corp | 4.11% |
| Document | Date |
|---|---|
| Quarterly report · Q3 2026 INTEGER HOLDINGS CORPORATION - Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Sales (6 months): $903.7 million vs. $913.9 million prior year (down 1.1%) • | 2026-08-04 |
| Material agreement · Q3 2026 INTEGER HOLDINGS CORPORATION – FORM 8-K SUMMARY HEADLINE NUMBERS • Merger price: $127 per share in cash for all outstanding common stock • Company t | 2026-08-04 |
| Reg FD disclosure · Q3 2026 INTEGER HOLDINGS CORPORATION – FORM 8-K SUMMARY HEADLINE NUMBERS • Integer Holdings Corporation agreed to be acquired for $127 per share • Total ent | 2026-08-03 |
| Results announced · Q3 2026 INTEGER HOLDINGS CORPORATION - Q2 2026 RESULTS SUMMARY HEADLINE NUMBERS • Sales: $464 million in Q2 2026, down 2.6% vs. Q2 2025 ($476 million). Orga | 2026-08-03 |
| Board / officer change · Q2 2026 INTEGER HOLDINGS CORPORATION – FORM 8-K SUMMARY Report Date: June 24, 2026 --- HEADLINE NUMBERS • No financial figures disclosed – This filing is a | 2026-06-26 |
| Quarterly report · Q2 2026 SUMMARY OF INTEGER HOLDINGS CORPORATION – Q1 2026 10-Q HEADLINE NUMBERS • Sales: $439.6 million (Q1 2026) vs. $437.4 million (Q1 2025) — essentially | 2026-04-30 |
| Proxy statement · Q2 2026 INTEGER HOLDINGS CORPORATION PROXY SUMMARY CEO TOTAL COMPENSATION & CHANGE • Payman Khales (President and CEO since October 24, 2025) compensation d | 2026-04-06 |
| Annual report FY2025 INTEGER HOLDINGS CORPORATION — ANNUAL REPORT 2025 SUMMARY HEADLINE NUMBERS • Market capitalization as of June 27, 2025: approximately $4.261 billion | 2026-02-23 |
Readable in the app.
| Announcement | Date |
|---|---|
| Agreement and Plan of Merger with Armstrong Parent and Armstrong Bidco Integer Holdings Corporation filed an 8-K on August 4, 2026, disclosing a merger agreement dated August 2, 2026. The company entered into an Agreement and Plan of Merger with Armstrong Paren | 2026-08-04 |
| Agreed to be acquired by KKR affiliate for $127 per share Integer Holdings Corporation has agreed to be acquired by KKR (Kohlberg Kravis Roberts) for $127 per share, valuing the company at approximately $5.7 billion in enterprise value. The deal wa | 2026-08-03 |
| KKR to acquire all outstanding shares in all-cash transaction Integer Holdings Corporation reported mixed Q2 2026 results with declining sales but stable adjusted earnings. Sales fell 2.6% to $464 million, with organic decline of 1.5%. The company's ma | 2026-08-03 |
| Q1 2026 results in line with outlook; updates full year 2026 guidance ranges Integer Holdings, a medical device company, reported Q1 2026 results that met expectations but revealed concerning trends. Sales grew only 0.5% to $440 million with modest 1.3% organic growt | 2026-04-30 |
| Full year 2025 results; 2026 outlook maintained; 2027 organic growth expected Integer Holdings, a medical device contract manufacturer, reported strong 2025 results with 8% sales growth to $1.854 billion and 21% adjusted earnings per share growth to $6.40. The company | 2026-02-19 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Integer Holdings Corp — free to start.
Google PlayApp StoreData updated 2026-09-18.